Axel Mescheder
Chief Executive Officer at Cristal Delivery BV
Axel Mescheder active positions
Companies | Position | Start | End |
---|---|---|---|
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Chief Executive Officer | 2018-11-01 | - |
Chief Tech/Sci/R&D Officer | 2018-11-01 | - |
Career history of Axel Mescheder
Former positions of Axel Mescheder
Companies | Position | Start | End |
---|---|---|---|
TOPOTARGET A/S | Chief Tech/Sci/R&D Officer | 2010-12-02 | 2012-10-30 |
MEDIGENE AG | Chief Tech/Sci/R&D Officer | - | 2008-09-14 |
MORPHOSYS AG | Chief Tech/Sci/R&D Officer | 2016-09-25 | - |
University of Cincinnati (Ohio) | Corporate Officer/Principal | - | - |
Training of Axel Mescheder
University of Kiel | Doctorate Degree |
Statistics
International
Germany | 4 |
Denmark | 2 |
United States | 2 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
MEDIGENE AG | Health Technology |
MORPHOSYS AG | Health Technology |
Private companies | 2 |
---|---|
Topotarget A/S
Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Axel Mescheder
- Experience